-
Stemline Therapeutics: Down, But Not Out
30 Jan 2020 18:05 GMT
… start to 2020 for Stemline Therapeutics (STML), or at … paragraphs below. Company Overview Stemline Therapeutics is a small biotech … , and SL-1001. Stemline Therapeutics currently has a market … the Biotech Forum, Busted IPO Forum, and Insiders Forum …
-
Stemline Therapeutics: Still A Believer
26 Sep 2019 19:01 GMT
… undervalued gem.
Company Overview Stemline Therapeutics (STML) is a New … 901, and SL-1001. Stemline Therapeutics currently has a market capitalization … the Biotech Forum, Busted IPO Forum, and Insiders Forum … 30 days. The Busted IPO Forum model portfolio has …
-
Stemline Therapeutics Still Has The 'Big Mo'
05 Aug 2019 10:49 GMT
… was Stemline Therapeutics (STML). This holding in the Busted IPO Forum … quarter results. Company Overview Stemline Therapeutics is a New York … , and SL-1001. Stemline Therapeutics currently has a market … exclusive marketplace, The Busted IPO Forum. Join our …
-
Stemline Therapeutics: Updating The Investment Thesis
03 Jun 2019 20:58 GMT
… paragraphs below. Company Overview: Stemline Therapeutics (STML) IPO'd in 2013 … to as tumor bulk. Stemline Therapeutics currently has a market … Biotech Forum, The Busted IPO Forum, and The Insiders … best small-cap Busted IPO stock ideas only to …
-
Wedbush: Trajectory For Stemline Therapeutics' Blood Cancer Drug Priced Into Stock
13 May 2019 14:38 GMT
Stemline Therapeutics Inc (NASDAQ: STML) reported a … Dates, Clinical Trials, Earnings And IPOs
Puma Biotech Shares Plunge After …
-
Stemline Therapeutics Has The 'Big Mo'
18 Mar 2019 17:05 GMT
… Stemline Therapeutics (STML), a member of the 20-stock Busted IPO … below. Company Overview: Stemline Therapeutics is a New York- … reiterated Buy ratings on Stemline Therapeutics during the week. Here … have no doubt that Stemline Therapeutics' Elzonris will …
-
Stemline Therapeutics: Derisked And Ready To Rally
26 Dec 2018 22:15 GMT
… look below. Company Overview: Stemline Therapeutics (STML) is a … company developing oncology therapeutics. Stemline Therapeutics currently has a market … its price target on Stemline Therapeutics to $30 from … Biotech Forum, The Busted IPO Forum, and The …
-
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12 Mar 2020 12:09 GMT
… )
Stealth BioTherapeutics Corp (NASDAQ: MITO)
Stemline Therapeutics Inc (NASDAQ: STML)
Stoke Therapeutics … close)
• Synlogic (after the close)
IPOs
Imara, a biopharma company that … rare hemoglobinopathies, priced its upsized IPO of 4.70 million shares …
-
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
28 Feb 2020 12:42 GMT
… )
Stealth BioTherapeutics Corp (NASDAQ: MITO)
Stemline Therapeutics Inc (NASDAQ: STML)
SurModics, Inc … : GLYC) (before the market open)
IPO
Passage Bio, a biotech developing …